Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
45,416,671
-
Number of holders
-
96
-
Total 13F shares, excl. options
-
38,729,939
-
Shares change
-
-6,297,774
-
Total reported value, excl. options
-
$134,392,918
-
Value change
-
-$121,107,695
-
Put/Call ratio
-
30%
-
Number of buys
-
64
-
Number of sells
-
-40
-
Price
-
$3.47
Significant Holders of THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share (THRD) as of Q1 2025
126 filings reported holding THRD - THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share as of Q1 2025.
THIRD HARMONIC BIO, INC. - Common Stock, par value $0.0001 per share (THRD) has 96 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 38,729,939 shares
of 45,416,671 outstanding shares and own 85% of the company stock.
Largest 10 shareholders include Atlas Venture Life Science Advisors, LLC (10,402,286 shares), ORBIMED ADVISORS LLC (5,779,071 shares), BML Capital Management, LLC (3,824,417 shares), Nantahala Capital Management, LLC (2,938,700 shares), TCG Crossover Management, LLC (2,505,424 shares), BVF INC/IL (2,372,933 shares), BlackRock, Inc. (1,479,618 shares), VANGUARD GROUP INC (1,159,600 shares), TANG CAPITAL MANAGEMENT LLC (929,727 shares), and Newtyn Management, LLC (635,150 shares).
This table shows the top 96 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.